- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
100
Companies with a Value score of at least 3, ordered by Value score
100 companies
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$14.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.59
7D
-1.2%
1Y
189.1%
Shanghai Henlius Biotech
Market Cap: HK$39.9b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$73.45
7D
-11.8%
1Y
219.3%
Shandong Boan Biotechnology
Market Cap: HK$8.4b
A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.
6955
HK$13.45
7D
-5.9%
1Y
46.4%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.2b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$7.28
7D
-5.5%
1Y
35.1%
Modern Chinese Medicine Group
Market Cap: HK$540.0m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.75
7D
2.7%
1Y
138.1%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.5b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.93
7D
-2.8%
1Y
14.9%
Everest Medicines
Market Cap: HK$19.3b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$54.70
7D
-6.9%
1Y
122.4%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.2b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$7.28
7D
-5.5%
1Y
35.1%
Keymed Biosciences
Market Cap: HK$20.9b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$70.80
7D
-4.0%
1Y
96.9%
Duality Biotherapeutics
Market Cap: HK$29.5b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$335.00
7D
-26.0%
1Y
n/a
Everest Medicines
Market Cap: HK$19.3b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$54.70
7D
-6.9%
1Y
122.4%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$14.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.59
7D
-1.2%
1Y
189.1%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$14.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.59
7D
-1.2%
1Y
189.1%
Shandong Boan Biotechnology
Market Cap: HK$8.4b
A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.
6955
HK$13.45
7D
-5.9%
1Y
46.4%
Hangzhou Tigermed Consulting
Market Cap: HK$50.0b
Provides contract research organization services in the People’s Republic of China and internationally.
3347
HK$47.80
7D
3.2%
1Y
67.4%
Keymed Biosciences
Market Cap: HK$20.9b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$70.80
7D
-4.0%
1Y
96.9%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.2b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$7.28
7D
-5.5%
1Y
35.1%
Hangzhou Tigermed Consulting
Market Cap: HK$50.0b
Provides contract research organization services in the People’s Republic of China and internationally.
3347
HK$47.80
7D
3.2%
1Y
67.4%
Everest Medicines
Market Cap: HK$19.3b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$54.70
7D
-6.9%
1Y
122.4%
Livzon Pharmaceutical Group
Market Cap: HK$32.5b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
1513
HK$34.50
7D
-5.3%
1Y
32.2%
Hangzhou Tigermed Consulting
Market Cap: HK$50.0b
Provides contract research organization services in the People’s Republic of China and internationally.
3347
HK$47.80
7D
3.2%
1Y
67.4%
China Medical System Holdings
Market Cap: HK$35.7b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.78
7D
-1.9%
1Y
85.2%
Livzon Pharmaceutical Group
Market Cap: HK$32.5b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
1513
HK$34.50
7D
-5.3%
1Y
32.2%
AIM Vaccine
Market Cap: HK$5.1b
Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.
6660
HK$4.19
7D
-10.9%
1Y
-1.4%
Hansoh Pharmaceutical Group
Market Cap: HK$211.5b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$34.94
7D
-3.5%
1Y
81.0%
China Medical System Holdings
Market Cap: HK$35.7b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.78
7D
-1.9%
1Y
85.2%
Shandong Boan Biotechnology
Market Cap: HK$8.4b
A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.
6955
HK$13.45
7D
-5.9%
1Y
46.4%
China Medical System Holdings
Market Cap: HK$35.7b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.78
7D
-1.9%
1Y
85.2%